Skip to content

Clinical trials

Completed Pulmonary Arterial Hypertension trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Status: Completed Country / region: Netherlands Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20062
20071
20082
20092
20102
20112
20121
20131
20141
20152
20161
20172
20192
20212
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion9
United Therapeutics6
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA2
GlaxoSmithKline2
Amsterdam UMC, location VUmc1
Bayer1
Bial - Portela C S.A.1
GB002, Inc.1
Gilead Sciences1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension27
Hypertension, Pulmonary9
Hypertension3
Cardiovascular Diseases1
Connective Tissue Diseases1
Familial Primary Pulmonary Hypertension1
Lung Diseases1
Respiratory Tract Diseases1
Vascular Diseases1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.